Sandbox:Mitra2: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 36: | Line 36: | ||
*Systoloic dysfunction (in HFrEF) | *Systoloic dysfunction (in HFrEF) | ||
*Diastoic dysfunction (in HFpEF) | *Diastoic dysfunction (in HFpEF) | ||
*[[ | *[[COVID-19-associated stress cardiomyopathy|COVID-19-associated stress cardiomyopathy]] [[(apical ballooning)]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*CT: [[Cardiomegaly]], [[Pulmonary edema]] | *CT: [[Cardiomegaly]], [[Pulmonary edema]] |
Revision as of 16:56, 20 July 2020
Diseases | Symptoms | Physical Examination | Diagnostic tests | Other Findings | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dyspnea on Exertion | Chest Pain | Hemoptysis | Fever | Tachypnea | Tachycardia | Chest X-ray | ECG | Echocardiography> | CT scan and CMRI | ||
COVID-19-associated heart failure | ✔ | - | ✔ | - | ✔ | ✔ |
|
|
|
|
Increased NT-proBNP and cardiac troponins levels |
COVID-19-associated pneumonia | ✔ (Usually high) | ✔ (Pleuritic) | ✔ | ✔ | ✔ | ✔ |
|
- | Increased inflammatory markers, including ESR, hs-CRP | ||
COVID-19-associated ARDS | ✔ | - | ✔ | ✔ | ✔ | ✔ |
|
- |
|
|
- |
COVID-19-associated myocarditis | ✔ | ✔ | - | ✔ | ✔ | ✔ |
|
|
|
|
Increased cardiac troponins level |
COVID-19-associated pulmonary embolism | ✔ (Usually sudden-onset) | ✔ (Pleauritic) | ✔ (If massive PE) | ✔ (Low-grade) | ✔ | ✔ |
|
|
|
|
|